Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
GLUE compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name
GLUE
Monte Rosa Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
GLUE
Monte Rosa Therapeutics, Inc.
vs
AMGN
Amgen Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
GLUE
Monte Rosa Therapeutics, Inc.
Change
10.39
· pre 10.70
· delayed
Mkt cap
$888.1M
Revenue
$9M
Q2 FY26
Revenue
$124M
FY25
AMGN
Amgen Inc
Change
460.67
· pre 463.52
· delayed
Pre-market
Nov 4 '26
delayed
Mkt cap
$249.4B
Revenue
$10.1B
Q2 FY26
Revenue
$36.8B
FY25
vs
Compare
Pre-market
Nov 4 '26
delayed
GLUE
Monte Rosa Therapeutics, Inc.
vs
AMGN
Amgen Inc
10.39
pre 10.70
delayed
Price
460.67
pre 463.52
delayed
$888.1M
Mkt cap
$249.4B
Q2 FY26
$9M
Revenue
$10.1B
Q2 FY26
FY25
$124M
Revenue
$36.8B
FY25
Change
Change
GLUE
10.39
vs
AMGN
460.67
Pre-market
Nov 4 '26
delayed
Co-movers
daily closes
Method
›
Moved together
GLUE
with
AMGN
Uncorrelated: r 0.12 · 499D.
No shared co-movers.
GLUE, solid
AMGN, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes